Bristol-Myers Squibb Company (BMY) reported an adjusted earnings per share (EPS) of $2.07, which beat the Zacks Consensus Estimate of$1.64.  In the year-ago quarter, BMY posted an adjusted EPS of $1.75.Total revenues of$12.2 billion surpassed the Zacks Consensus Estimate of $11.5 billion. The top line also increased 9% from the year-ago period’s level, primarily driven by strong growth portfolio performance and an increase in Eliquis sales.BMY’s shares are trading up following the results.The company’s sh ...